These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 25008926)
1. Impact of HLA selection pressure on HIV fitness at a population level in Mexico and Barbados. Juarez-Molina CI; Payne R; Soto-Nava M; Avila-Rios S; Valenzuela-Ponce H; Adland E; Leitman E; Brener J; Muenchhoff M; Branch S; Landis C; Reyes-Teran G; Goulder P J Virol; 2014 Sep; 88(18):10392-8. PubMed ID: 25008926 [TBL] [Abstract][Full Text] [Related]
2. Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity. Tsai MC; Singh S; Adland E; Goulder P J Virol; 2020 Jun; 94(13):. PubMed ID: 32321820 [TBL] [Abstract][Full Text] [Related]
3. Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient. Brener J; Gall A; Hurst J; Batorsky R; Lavandier N; Chen F; Edwards A; Bolton C; Dsouza R; Allen T; Pybus OG; Kellam P; Matthews PC; Goulder PJR Retrovirology; 2018 Jan; 15(1):7. PubMed ID: 29338738 [TBL] [Abstract][Full Text] [Related]
4. Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection. Brockman MA; Brumme ZL; Brumme CJ; Miura T; Sela J; Rosato PC; Kadie CM; Carlson JM; Markle TJ; Streeck H; Kelleher AD; Markowitz M; Jessen H; Rosenberg E; Altfeld M; Harrigan PR; Heckerman D; Walker BD; Allen TM J Virol; 2010 Nov; 84(22):11937-49. PubMed ID: 20810731 [TBL] [Abstract][Full Text] [Related]
5. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection. Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209 [TBL] [Abstract][Full Text] [Related]
6. Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals. Sakai K; Chikata T; Brumme ZL; Brumme CJ; Gatanaga H; Oka S; Takiguchi M Retrovirology; 2015 Nov; 12():98. PubMed ID: 26585907 [TBL] [Abstract][Full Text] [Related]
8. Two Distinct Mechanisms Leading to Loss of Virological Control in the Rare Group of Antiretroviral Therapy-Naive, Transiently Aviremic Children Living with HIV. Vieira VA; Adland E; Grayson NE; Csala A; Richards F; Dacon C; Athavale R; Tsai MH; D'Souza R; Muenchhoff M; Bonsall D; Jooste P; Goulder PJR J Virol; 2022 Jan; 96(2):e0153521. PubMed ID: 34757843 [TBL] [Abstract][Full Text] [Related]
9. Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses. Murakoshi H; Koyanagi M; Chikata T; Rahman MA; Kuse N; Sakai K; Gatanaga H; Oka S; Takiguchi M J Virol; 2017 Feb; 91(4):. PubMed ID: 27903797 [TBL] [Abstract][Full Text] [Related]
10. HLA Class I-Mediated HIV-1 Control in Vietnamese Infected with HIV-1 Subtype A/E. Chikata T; Tran GV; Murakoshi H; Akahoshi T; Qi Y; Naranbhai V; Kuse N; Tamura Y; Koyanagi M; Sakai S; Nguyen DH; Nguyen DT; Nguyen HT; Nguyen TV; Oka S; Martin MP; Carrington M; Sakai K; Nguyen KV; Takiguchi M J Virol; 2018 Mar; 92(5):. PubMed ID: 29237835 [TBL] [Abstract][Full Text] [Related]
11. Additive contribution of HLA class I alleles in the immune control of HIV-1 infection. Leslie A; Matthews PC; Listgarten J; Carlson JM; Kadie C; Ndung'u T; Brander C; Coovadia H; Walker BD; Heckerman D; Goulder PJ J Virol; 2010 Oct; 84(19):9879-88. PubMed ID: 20660184 [TBL] [Abstract][Full Text] [Related]
12. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function. Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081 [TBL] [Abstract][Full Text] [Related]
13. Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes. Du Y; Zhang TH; Dai L; Zheng X; Gorin AM; Oishi J; Wu TT; Yoshizawa JM; Li X; Yang OO; Martinez-Maza O; Detels R; Sun R mBio; 2017 Nov; 8(6):. PubMed ID: 29184023 [TBL] [Abstract][Full Text] [Related]
14. Frequencies of Gag-restricted T-cell escape "footprints" differ across HIV-1 clades A1 and D chronically infected Ugandans irrespective of host HLA B alleles. Serwanga J; Nakiboneka R; Mugaba S; Magambo B; Ndembi N; Gotch F; Kaleebu P Vaccine; 2015 Mar; 33(14):1664-72. PubMed ID: 25728323 [TBL] [Abstract][Full Text] [Related]
15. HLA-B*57 Micropolymorphism shapes HLA allele-specific epitope immunogenicity, selection pressure, and HIV immune control. Kloverpris HN; Stryhn A; Harndahl M; van der Stok M; Payne RP; Matthews PC; Chen F; Riddell L; Walker BD; Ndung'u T; Buus S; Goulder P J Virol; 2012 Jan; 86(2):919-29. PubMed ID: 22090105 [TBL] [Abstract][Full Text] [Related]
16. HLA-A*7401-mediated control of HIV viremia is independent of its linkage disequilibrium with HLA-B*5703. Matthews PC; Adland E; Listgarten J; Leslie A; Mkhwanazi N; Carlson JM; Harndahl M; Stryhn A; Payne RP; Ogwu A; Huang KH; Frater J; Paioni P; Kloverpris H; Jooste P; Goedhals D; van Vuuren C; Steyn D; Riddell L; Chen F; Luzzi G; Balachandran T; Ndung'u T; Buus S; Carrington M; Shapiro R; Heckerman D; Goulder PJ J Immunol; 2011 May; 186(10):5675-86. PubMed ID: 21498667 [TBL] [Abstract][Full Text] [Related]